Koki Nakamura

Recapitulation of Clinical Individual Susceptibility to Drug-Induced QT Prolongation in Healthy Subjects Using iPSC-Derived Cardiomyocytes

S. Izumo, T. Shinozawa, Keiji Yamamoto, 2017, Stem cell reports.

Pharmacokinetics, Safety, and Tolerability of Vortioxetine Following Single‐ and Multiple‐Dose Administration in Healthy Japanese Adults

A. Nishimura, Koki Nakamura, Kumi Matsuno, 2017, Clinical pharmacology in drug development.

Pharmacokinetic Drug–Drug Interactions Between Vonoprazan and Low-Dose Aspirin or Nonsteroidal Anti-inflammatory Drugs: A Phase 2, Open-Label, Study in Healthy Japanese Men

Y. Sakurai, A. Nishimura, H. Okamoto, 2016, Clinical Drug Investigation.

Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study

Y. Sakurai, A. Nishimura, H. Okamoto, 2016, Advances in Therapy.

Efficacy and safety of a 60-week treatment with candesartan in Japanese patients with mild to moderate chronic heart failure.

M. Yano, M. Matsuzaki, Kazuhiro Yamamoto, 2013, Journal of cardiology.